of 26
7/31/2019 Lecture 11 cGMP
1/26
cGMPEleven Lecture
7/31/2019 Lecture 11 cGMP
2/26
Intermediate and Bulk Products
1. Intermediate and bulk products should be kept underappropriate conditions
2. Intermediate and bulk products purchased as such should behandled as were starting materials .
Finished Products
1. Finished products should be held in quarantine until their final
release .2. The evaluation of finished products and documentation
necessary for release of a product for sale .
7/31/2019 Lecture 11 cGMP
3/26
Rejected and Recovered Materials
1. Rejected materials and products should be clearly marked as
such and stored separately in restricted areas . They should
either returned to the suppliers or reprocessed or destroyed .
2. The reprocessing of the rejected products is permitted only ifthe product quality is not affected i.e. if the product
specification is met .
Recalled Products
Recalled products should be identified and stored separately ina secure area until a decision is taken on their fate .
7/31/2019 Lecture 11 cGMP
4/26
Documentation
The documents required are :1. Labels :Labels applied to containers, equipment or premises should be clear and in
companysagreed format . It is helpful in addition to wording on the labels to use colors to
indicatestatus ( quarantined, accepted, rejected, or clean ) .The label for finished product should bearing the following information :a. The name of the drug productb. A list of active ingredients .c. The batch number assigned by the manufacturer .
d. The expiry date in an uncooked form .e. Any special storage conditions or handling precautions that necessaryf. Directions for use, and warnings and precautions that necessary .g. The name and address of the manufacturer or company .
7/31/2019 Lecture 11 cGMP
5/26
Specifications and Testing Procedures
1. Testing procedures described in documents should be validated
before they are adopted for testing .
2. There should be appropriately authorized and dated
specifications including : tests on identity , content uniformity ,
purity and quality for staring and packaging materials andfinished products . Also specification for water , solvent , and
reagents used in production .
3. Each specification should be approved and maintained by the
quality control unit .4. Periodic revisions of the specifications may be necessary to
comply with new editions of Pharmacopoeia .
7/31/2019 Lecture 11 cGMP
6/26
Specifications for Starting and Packaging materials
Specifications for starting and primary or printedpackaging materials should provide, a description of thematerials including :
a. The designated name and internal code reference .
b. The reference to a pharmacopoeia monograph .c. Qualitative and quantitative requirements with acceptance
limits .d. The supplier and the original producer of the materialse. Directions for sampling and testing .
f. A specimen of the printed materials .g. Storage conditions and precautions .j. The maximum period of storage before re-examination
7/31/2019 Lecture 11 cGMP
7/26
Specifications For Finished Products
Specifications for finished products should include :
1. The designated name of the product and the code reference
where applicable .
2. The designated name of the active ingredients .
3. The formula or a reference to the formula .
4. A description of the dosage form and package details .
5. Directions of sampling and testing or a reference to procedure .
6. The qualitative and quantitative requirements with acceptancelimits .
7. The storage conditions and precautions .
8. The shelf-life .
7/31/2019 Lecture 11 cGMP
8/26
Master Formulae
A formally authorized master formula should exist for
each product and batch size to be manufactured .
The master formula should include :
1. The name of the product .2. A description of the dosage form, strength and batch size
3. A list of all starting materials to be used with the amount of each .
4. A statement of the expected final yield with the acceptable limits .
5. A statement of the processing location and the principleequipment to be used .
7/31/2019 Lecture 11 cGMP
9/26
Master Formulae ( cont..)
6. The methods or the reference to the methods to be used for
preparing the critical equipment e.g. cleaning, assembling,
calibrating and sterilization .
7. Detailed stepwise processing instructions .
8. The instructions for any in-process controls with their limits .
9. The requirements for storage of the products, including the
container, the labeling etc. .10. Any special precautions to be observed .
7/31/2019 Lecture 11 cGMP
10/26
Packaging Instructions
Formally authorized packaging instructions should existfor each product, pack size and type . These should
include the following :
1. The name of the product .
2. A description of its pharmaceutical form, its strength and routeof administration .
3. The pack size expressed in terms of the number, weight, orvolume of the product in the final container .
4. A complete list of all packaging materials required for astandard batch size, including quantities, sizes, and types withthe code number relating to the specifications for eachpackaging materials .
7/31/2019 Lecture 11 cGMP
11/26
Packaging Instructions ( cont.. )
5. Example of the printed packaging materials indicating where
the batch number and expiry date of the product have been
marked .
6. Special precautions to be observed including examination ofthe packaging area and equipment in order to ascertain the
line clearance before operations begin .
7. A description of the packaging operation and equipment to be
used .8. Details of in-process controls with instructions for sampling and
acceptance limits .
7/31/2019 Lecture 11 cGMP
12/26
Batch Processing Records
1. A batch processing record should be kept for each batchprocessed .
2. Before any processing begins a check should be made that theequipment and work station are clear of previous products,documents, or materials not required for the process, and the
equipment is clean and suitable for use . This check should berecorded .
3. During the processing the following information should berecorded at the time each action is taken :
i. The name of the product .
Ii. The number of the batch being manufactured .Iii. Dates and times of the beginning of stages and completion of
production .
7/31/2019 Lecture 11 cGMP
13/26
Batch Processing Records ( cont.. )
iv. The name of the person responsible for each stage ofproduction .
v. The initials of the operator of different steps of production andof person who checked each of these operations .
vi. The batch number / control number and the quantity of eachstarting material actually weighed .
vii. Any relevant processing operation and the major equipmentused .
viii. The in-process controls performed, and the results obtained .ix. The the yield of the product with explanations for deviations
from the expected yield .
7/31/2019 Lecture 11 cGMP
14/26
Batch Packaging Records
It should be based on the relevant parts of the packaging
instructions . It include the following information :
1. Before any packaging operation begins, checks should be madethat the equipment and workstation are clear .
2. The name of the product, the batch number, and the quantityof bulk product to be packed, as well as the quantity of thefinished product that will be obtained .
3. The date and time of the packaging operations .
4. The name of the responsible person carrying out the packagingoperation .
5. The checks made for identity and conformity with thepackaging instructions including the in-process controls .
7/31/2019 Lecture 11 cGMP
15/26
Batch Packaging Records ( cont.. )
6. Details of the packaging operations carried out .
7. Samples of the printed packaging materials used .
8. Notes on any special problems including any deviation from
packaging instructions .
9. The quantities of all printed materials and bulk product issued,used, destroyed, or returned to the stock and the quantities of
the product obtained to permit an adequate reconciliation .
7/31/2019 Lecture 11 cGMP
16/26
Standard Operating Procedures ( SOPs)
There should be standard operating procedures and
records for the receipt of each delivery of starting
material and primary and printed packaging material .
The records for the receipts should include :
1. The name of the material on the delivery note and the containers .
2. The in house name / code number of material
3. The date of the receipt
4. The suppliers name and if possible the manufacturers name .5. The manufacturers batch or reference number
6. The total quantity and the number of containers received .
7. Any relevant comment e.g. state of the containers .
7/31/2019 Lecture 11 cGMP
17/26
SOP for Sampling
The sampling instructions should include :
1. The method of sampling and the sampling plan .
2. The equipment to be used .
3. Any precautions to be observed to avoid contamination of the
material or any deterioration in its quality .
4. The amounts of sample to be taken .
5. Instructions for any required subdivision of the sample
6. The type of sample containers to be used .7. Any specific precautions to be observed specially in regard to
the sampling of sterile material .
7/31/2019 Lecture 11 cGMP
18/26
Good Practices in Production and Quality Control
1. All handling of materials and products should be done in
accordance with written procedures or instructions .
2. Any deviation from instructions should be avoided and if it
occur they should be approved in writing by a designated
person .
3. Checks on yields and reconciliation of quantities should be
carried out to ensure there are no discrepancies outside
acceptable limits .
4. Operations on different products should not be carried out
simultaneously or consecutively in the same room unless is no
risk of mix-up or cross-contamination .
7/31/2019 Lecture 11 cGMP
19/26
Good Practices in Production and Quality Control
( cont.. )
5. Access to production premises should be restricted to
authorized personnel .
6. At all the times during processing all materials, bulk containers,
equipment, and rooms used should be labeled that the product
or material being processed , its strength, the batch number
and the stage of production .
7. In-process controls are performed within the production area .
7/31/2019 Lecture 11 cGMP
20/26
Prevention of Cross-Contamination and Bacterial
Contamination in Production
Cross-contamination can be avoided by technical or
organizational measures , for example :
1. Production in segregated areas or by campaign followed byappropriate cleaning .
2. Providing appropriate airlocks, pressure differentials, airextraction .
3. Wearing protective clothing in areas where products withspecial risk of cross-contamination are processed
4. Using cleaning procedures of known effectiveness .
5. Using closing system of production .6. Testing for residues .
7. Using cleanliness status labels on equipment .
7/31/2019 Lecture 11 cGMP
21/26
Good Practices in Quality Control
Quality control is concerned with :Sampling , Specifications , Testing as well as with
organization, documentation , and release procedures .
Quality control is not confined to laboratory operations,
but must be involved in all decisions that may concern
the quality of the product .
Quality control unit should perform the following :
1. All test procedure for each material or product .
2. Samples should be representative of the batches of material
from which they are taken in accordance with the approved
written procedure .
7/31/2019 Lecture 11 cGMP
22/26
Good Practices in Quality Control ( cont.. )
3. Sampling should be carried out so as to avoid contamination orother adverse effects on quality .
4. Sampling equipment should be cleaned before and after each useand stored separately from other laboratory equipment .
5. Each sample container should be a label indicating :a. The name of the sample material .
b. The batch or lot number .
c. The number of container from which the sample has
been taken .d. The signature of the person who has taken the sample .
e. The date of sampling .
7/31/2019 Lecture 11 cGMP
23/26
Test Requirements
Before releasing a staring or packaging material for use,the quality control manager should ensure that :
1. The materials have been tested for conformity with
specifications for identity , strength , purity and other
quality parameters .
2. An identity test should be conducted on a sample from each
container of starting materials .
3. Each batch of printed packaging materials must be examined
following receipt .
4. A certificate of analysis may be accepted from supplier,
certificate must be originals, and the certificate must contain
the following information :
7/31/2019 Lecture 11 cGMP
24/26
Test Requirements ( cont.. )
4. A certificate of analysis may be accepted from supplier,
certificate must be originals, and the certificate must containthe following information :
1. Identification of the issuing supplier, signature of the manager
or director of QC lab .
2. The name and the batch number of the material tested .
3. A statement of specifications and methods used .
4. A statement of test results obtained and the date of testing .
7/31/2019 Lecture 11 cGMP
25/26
Stability Studies
1. The QC unit should evaluate the quality and stability of finishedproducts and when necessary of starting materials andintermediate products .
2. The QC unit should establish expiry dates and shelf-lifespecifications on the basis of stability tests related to storageconditions .
3. A written programmed for ongoing stability determinationshould be developed and implemented to include :
7/31/2019 Lecture 11 cGMP
26/26
Stability Studies ( cont.. )
a. A complete description of the drug used in the study .
b. A complete testing parameters and methods for potency, and
physical characteristics .
c. Provision for inclusion of sufficient number of batches
d. The testing schedule for each drug .
e. Provision for special storage conditions .
f. Provision for adequate sample retention .g. A summary of all data generated, including evaluation and the
conclusion of the study .